Foresite Capital Management LLC

https://www.foresitecapital.com

LinkedIn: https://www.linkedin.com/company/foresite-capital-management

Foresite Capital is a multi-stage healthcare and life sciences investment firm with $2 billion in assets under management. The firm seeks to address areas of great unmet medical need by funding and supporting transformative healthcare businesses. Foresite Capital has a uniquely collaborative investment model that benefits from insights generated by its multidisciplinary team of scientists, clinicians, investment analysts and engineers. It applies a rigorous scientific and data-driven approach to investment analysis. Foresite Capital understands the unique business models in healthcare and works closely with the firm’s portfolio companies at all stages of their lifecycle. The firm has offices in San Francisco and New York. *

	Start	2016-03-17 existent
	Industry	finance
	Industry 2	venture capital
	Person	Tananbaum, James (Jim) (Foresite Capital 201609 CEO + Managing Director + Co-Founder)

	Region	San Francisco, CA
	Country	United States (USA)
	Street	600 Montgomery Street Suite 4500
	City	94111 San Francisco, CA
	Tel	+1-415-877-4887
		Address record changed: 2024-01-05

Basic data	Employees	n. a.
	Currency	USD
	Annual sales	2,000,000,000 (capital under management (2018) 2018-12-10)

		* Document for »About Section«: Genomics plc. (12/10/18). "Press Release: Genomics plc Today Announces Second Close of Its Series B Financing, Raising a further £8 Million, Bringing the Total Round to £33 million ". Oxford.

		Record changed: 2024-01-03

Picture Berlin Partner Voices Robinson Data for Precision Medicine 650x200px

More documents for Foresite Capital Management LLC

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)